S T A T E O F N E W Y O R K
________________________________________________________________________
3283
2025-2026 Regular Sessions
I N A S S E M B L Y
January 27, 2025
___________
Introduced by M. of A. BORES -- read once and referred to the Committee
on Health
AN ACT to amend the public health law, in relation to establishing mini-
mum protocol requirements for gene synthesis providers and manufactur-
ers of gene synthesis equipment
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Short title. This act shall be known and may be cited as
the "bioterrorism prevention act".
§ 2. The public health law is amended by adding a new article 32-B to
read as follows:
ARTICLE 32-B
GENE SYNTHESIS LABS
SECTION 3230. MINIMUM PROTOCOL REQUIREMENTS FOR GENE SYNTHESIS PROVIDERS
AND MANUFACTURERS OF GENE SYNTHESIS EQUIPMENT.
§ 3230. MINIMUM PROTOCOL REQUIREMENTS FOR GENE SYNTHESIS PROVIDERS AND
MANUFACTURERS OF GENE SYNTHESIS EQUIPMENT. 1. ANY GENE SYNTHESIS
PROVIDER OR MANUFACTURER OF GENE SYNTHESIS EQUIPMENT IN THE STATE SHALL
OPERATE IN ACCORDANCE WITH INTERNATIONAL GENE SYNTHESIS CONSORTIUM
PROTOCOLS.
2. GENE SYNTHESIS PROVIDERS AND MANUFACTURERS OF GENE SYNTHESIS EQUIP-
MENT SHALL, AT A MINIMUM:
(A) SCREEN SYNTHETIC GENE ORDERS TO IDENTIFY REGULATED PATHOGEN
SEQUENCES AND OTHER POTENTIALLY DANGEROUS SEQUENCES;
(B) SCREEN THE COMPLETE DNA SEQUENCE OF EVERY SYNTHETIC GENE ORDER
AGAINST THE DNA SEQUENCES IN A COMMON REGULATED PATHOGEN DATABASE (RPD)
AND AGAINST ALL ENTRIES FOUND IN ONE OR MORE OF THE INTERNATIONALLY
COORDINATED SEQUENCE REFERENCE DATABANKS (SUCH AS NCBI/GENBANK,
EBI/EMBL, OR DDBJ). THE RPD SHALL INCLUDE DATA FROM ALL ORGANISMS ON THE
FEDERAL HHS AND USDA SELECT AGENTS AND TOXINS LIST, THE AUSTRALIA GROUP
LIST OF HUMAN AND ANIMAL PATHOGENS AND TOXINS FOR EXPORT CONTROL AND
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD04229-01-5
A. 3283 2
OTHER NATIONAL LISTS OF REGULATED PATHOGENS. AS A BASELINE, GENE SYNTHE-
SIS PROVIDERS AND MANUFACTURERS OF GENE SYNTHESIS EQUIPMENT SHALL SCREEN
AGAINST ALL PATHOGEN AND TOXIN GENES AS SPECIFIED IN THE FEDERAL SELECT
AGENTS AND TOXINS LIST, THE FEDERAL COMMERCE CONTROL LIST, AND THE EURO-
PEAN UNION LIST OF DUAL-USE ITEMS;
(C) TRANSLATE ALL SIX READING FRAMES OF EACH SYNTHETIC GENE ORDERED OR
REQUESTED INTO AN AMINO ACID SEQUENCE. SUCH SEQUENCE SHALL BE SCREENED
AGAINST THE PROTEIN SEQUENCES DERIVED FROM THE RPD DATABASE DESCRIBED IN
THIS SUBDIVISION;
(D) USE AUTOMATED HOMOLOGY SCREENING AS A FILTER TO IDENTIFY PATHOGEN
AND TOXIN DNA SEQUENCES. WHEN AUTOMATED SCREENING IDENTIFIES A POTENTIAL
PATHOGEN OR TOXIN SEQUENCE, THE ORDER SHALL BE REVIEWED BY A HUMAN
EXPERT USING COMMON SCREENING CRITERIA AND SHALL BE EITHER ACCEPTED,
ACCEPTED WITH A REQUIREMENT FOR ADDITIONAL CUSTOMER REVIEW, OR REJECTED;
(E) REQUIRE IDENTIFICATION DATA FROM ALL POTENTIAL CUSTOMERS FOR
SYNTHETIC GENES, INCLUDING AT A MINIMUM A SHIPPING ADDRESS, INSTITUTION
NAME, COUNTRY, TELEPHONE NUMBER, AND EMAIL ADDRESS. GENE SYNTHESIS
PROVIDERS SHALL NOT SHIP TO PO BOXES;
(F) SCREEN POTENTIAL CUSTOMERS AGAINST THE FEDERAL OFFICE OF FOREIGN
ASSETS CONTROL'S SPECIALLY DESIGNATED NATIONALS AND BLOCKED PERSONS LIST
(SDN), THE FEDERAL DEPARTMENT OF STATE'S DEBARRED LIST, AND THE FEDERAL
BUREAU OF INDUSTRY AND SECURITY'S DENIED PERSONS LIST, ENTITY LIST, AND
UNVERIFIED LIST;
(G) REQUIRE ADDITIONAL CUSTOMER SCREENING BEFORE ACCEPTING ORDERS FOR
DNA SEQUENCES FROM REGULATED PATHOGENS OR TOXINS. ALTHOUGH THE FEDERAL
SELECT AGENT REGULATIONS AND THE EUROPEAN COMMISSION REGULATIONS DO NOT
RESTRICT ACCESS TO ALL SELECT AGENT GENES, GENE SYNTHESIS PROVIDERS AND
MANUFACTURERS OF GENE SYNTHESIS EQUIPMENT SHALL SUPPLY GENES FROM REGU-
LATED PATHOGENS ONLY TO RESEARCHERS IN BONA FIDE GOVERNMENT LABORATO-
RIES, UNIVERSITIES, NON-PROFIT RESEARCH INSTITUTIONS, OR INDUSTRIAL
LABORATORIES DEMONSTRABLY ENGAGED IN LEGITIMATE RESEARCH. CUSTOMERS
ORDERING SEQUENCES UNIQUE TO ORGANISMS LISTED IN THE FEDERAL SELECT
AGENT OR THE UNITED STATES COMMERCE CONTROL LIST THAT ENDOW OR ENHANCE
PATHOGENICITY SHALL PROVIDE A WRITTEN DESCRIPTION OF THE INTENDED USE OF
THE SYNTHETIC PRODUCT. GENE SYNTHESIS PROVIDERS AND MANUFACTURERS OF
GENE SYNTHESIS EQUIPMENT SHALL VERIFY INDEPENDENTLY: (I) THE IDENTITY OF
THE POTENTIAL CUSTOMER AND PURCHASING ORGANIZATION; AND (II) THAT THE
DESCRIBED USE IS CONSISTENT WITH THE ACTIVITIES OF THE PURCHASING ORGAN-
IZATION;
(H) USE THE CURRENT RECOMMENDATIONS FROM THE FEDERAL CENTERS FOR
DISEASE CONTROL AND PREVENTION OR THE UNITED STATES DEPARTMENT OF AGRI-
CULTURE TO DETERMINE WHICH DNA SEQUENCES ARE SELECT AGENTS AS RECOMBI-
NANT DNA FRAGMENTS. GENE SYNTHESIS PROVIDERS AND MANUFACTURERS OF GENE
SYNTHESIS EQUIPMENT SHALL SUPPLY GENES WITH SUCH SEQUENCES ONLY IF THE
SUPPLIER AND THE CUSTOMER ARE ABLE TO COMPLY WITH ALL SELECT AGENT REGU-
LATIONS APPLICABLE TO SUCH GENE;
(I) IN GENERAL, ONLY SELL DNA OR FRAGMENTS OF REGULATED PATHOGENS TO
BONA FIDE END-USERS. GENE SYNTHESIS PROVIDERS AND MANUFACTURERS OF GENE
SYNTHESIS EQUIPMENT SHALL NOT SELL OR SHIP SUCH MATERIAL TO DISTRIBUTORS
OR OTHER RESELLERS, UNLESS SUCH COMPANIES IDENTIFY THE END-USER RECEIV-
ING THE PRODUCTS AND DEMONSTRATE THEIR COMPLIANCE WITH EVERY REQUIREMENT
OTHERWISE APPLICABLE TO SUCH END-USER;
(J) RETAIN RECORDS OF EVERY GENE SYNTHESIZED AND DELIVERED FOR A MINI-
MUM OF EIGHT YEARS AFTER SHIPPING, INCLUDING AT LEAST THE FOLLOWING:
(I) THE SYNTHETIC DNA SEQUENCE; (II) THE VECTOR (IF APPLICABLE); AND
(III) THE RECIPIENT'S IDENTITY AND SHIPPING ADDRESS;
A. 3283 3
(K) RETAIN RECORDS OF EVERY GENE SEQUENCE SCREENING RESULT FOR AT
LEAST EIGHT YEARS;
(L) RESERVE THE RIGHT TO REFUSE TO FILL ANY ORDER AND TO NOTIFY OTHER
GENE SYNTHESIS PROVIDERS AND MANUFACTURERS OF GENE SYNTHESIS EQUIPMENT
AND AUTHORITIES UPON IDENTIFYING POTENTIALLY PROBLEMATIC ORDERS;
(M) ESTABLISH AN UP-TO-DATE CONTACT LIST OF NATIONAL LAW ENFORCEMENT
AGENCIES WITH WHOM TO SHARE INFORMATION AND REPORT ANY POTENTIAL MISUSE
OF SYNTHETIC GENES;
(N) REPORT ANY REQUEST FOR A GENE ASSOCIATED WITH THE PATHOGENICITY OF
AN ORGANISM RECEIVED FROM A SUSPICIOUS POTENTIAL CUSTOMER OR POTENTIAL
CUSTOMER FAILING TO ESTABLISH THEIR LEGITIMACY TO LAW ENFORCEMENT OFFI-
CIALS; AND
(O) SYNTHESIZE GENE SEQUENCES UNIQUE TO AND DERIVED FROM VARIOLA
(SMALLPOX) VIRUS DNA ONLY IN ADHERENCE WITH GUIDELINES ESTABLISHED BY
THE WORLD HEALTH ORGANIZATION'S ADVISORY COMMITTEE FOR VARIOLA VIRUS
RESEARCH.
§ 3. This act shall take effect immediately.